Cisplatin plus vinorelbine as induction treatment in stage IIIA non-small cell lung cancer

Survival rates in patients with stage IIIA non-small cell lung cancer (NSCLC) remain low despite curative treatment. This is due to tumor recurrence at distant sites. The aim of neoadjuvant chemotherapy (NA-CT) is to eradicate occult micrometastatic disease and improve survival in patients that are...

Descripción completa

Detalles Bibliográficos
Autores principales: Palka, Magda, Sanchez, Antonio, Córdoba, Mar, Nuevo, Gema Díaz, De Ugarte, Andrés Varela, Cantos, Blanca, Méndez, Miriam, Calvo, Virginia, Maximiano, Constanza, Provencio, Mariano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403378/
https://www.ncbi.nlm.nih.gov/pubmed/28454304
http://dx.doi.org/10.3892/ol.2017.5620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403378/
https://www.ncbi.nlm.nih.gov/pubmed/28454304
http://dx.doi.org/10.3892/ol.2017.5620

Ejemplares similares